In the United States alone, over 550,000 people will die from cancer this year, exceeding the number of U.S. combat deaths for the entire 20th century.

“In my 30 years of cancer research, until Piedmont’s current studies with Taxolog agents, I have never encountered a series of compounds that demonstrate such outstanding antitumor activity against difficult-to-reach solid tumors in nude mice with a single administration of each agent. This series of compounds has excellent potential to contribute one or more promising new anticancer drug candidates.”

--Dr. Daniel Dexter, Senior Research Advisor, Piedmont Research Center

Taxolog, Inc., is a family of people working together to make a difference in the treatment of cancer and other diseases.

This website is your link to an organization committed to producing solutions. Examine this site and uncover Taxolog’s story, gain insight into current research ventures and accomplishments, learn about the people behind the discoveries and more. Be sure to bookmark this page for future reference.